Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDH1 | O75874 | 16/20 | 0.70 |
| ▸ | MAPT | P10636 | 2/20 | 0.60 |
| ▸ | KCNJ6 | P48051 | 1/20 | 0.57 |
| ▸ | KCNJ5 | P48544 | 1/20 | 0.57 |
| ▸ | KCNJ3 | P48549 | 1/20 | 0.57 |
| ▸ | TP53 | P04637 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17102998 | 0.90 | IDH1 (0.65) | IDH1MAPTKCNJ6KCNJ5KCNJ3 | |
| SCHEMBL28705138 | 0.88 | IDH1 (0.60) | IDH1MAPTKCNJ6KCNJ5KCNJ3 | |
| SCHEMBL17103000 | 0.87 | GAA (0.59) | IDH1MAPTKCNJ6KCNJ5KCNJ3 | |
| SCHEMBL30294174 | 0.87 | GAA (0.59) | IDH1MAPTKCNJ6KCNJ5KCNJ3 | |
| SCHEMBL633994 | 0.87 | ALDH1A1 (0.68) | IDH1MAPTTP53 | |
| SCHEMBL28935253 | 0.86 | DDX3X (0.55) | IDH1MAPTKCNJ6KCNJ5KCNJ3 | |
| SCHEMBL28691818 | 0.85 | IDH1 (0.60) | IDH1KCNJ6KCNJ5KCNJ3 | |
| SCHEMBL28935235 | 0.85 | IDH1 (0.60) | IDH1MAPTKCNJ6KCNJ5KCNJ3 | |
| SCHEMBL2303216 | 0.84 | LMNA (0.63) | IDH1MAPTKCNJ6KCNJ5KCNJ3 | |
| SCHEMBL9479365 | 0.84 | MEN1 (0.61) | IDH1MAPTTP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2923851-B1 | RECORDING MATERIAL PRODUCED USING NON-PHENOL COMPOUND | NIPPON SODA CO (JP) | 2019-05-01 | — | — | EP | disclosed |
| US-9518011-B2 | Recording material produced using non-phenol compound | NIPPON SODA CO., LTD. (JP) | 2016-12-13 | — | — | US | disclosed |
| US-20150284321-A1 | RECORDING MATERIAL PRODUCED USING NON-PHENOL COMPOUND | NIPPON SODA CO., LTD. (JP) | 2015-10-08 | — | — | US | disclosed |
| EP-2923851-A1 | RECORDING MATERIAL PRODUCED USING NON-PHENOL COMPOUND | Nippon Soda Co., Ltd. (JP) | 2015-09-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150284321-A1 | RECORDING MATERIAL PRODUCED USING NON-PHENOL COMPOUND | CYP19A1, ALPG, ALPP | IDH1 1917/4885MAPT 3343/4885KCNJ6 366/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.